Interact to see
Advertisement
Advertisement
JALRX vs PACAX
JALRX vs PACAX Comparison
Open Charts JALRX vs PACAX
JHancock Multimanager Lifestyle Cnsrv A
Price$12.39
Change+$0.03 (+0.24%)
VolumeN/A
Net Assets1.59B
Putnam Dynamic Asset Allocation Cnsrv A
Price$11.27
Change+$0.05 (+0.45%)
VolumeN/A
Net Assets575.59M
JALRX vs PACAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
JALRX vs. PACAX commentary
Sep 09, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JALRX is a Hold and PACAX is a Buy.
FUNDAMENTALS
Fundamentals
JALRX has more cash in the bank: 1.59B vs. PACAX (576M). JALRX pays higher dividends than PACAX: JALRX (3.63) vs PACAX (3.40). JALRX was incepted earlier than PACAX: JALRX (20 years) vs PACAX (32 years). JALRX (1.23) is less costly to investors than PACAX (1.00). PACAX is a more actively managed with annual turnover of: 372.00 vs. JALRX (16.00). PACAX initial investment is less costly to investors than JALRX (5%) vs JALRX (5%). PACAX has a lower initial minimum investment than JALRX: PACAX (0) vs JALRX (1000). JALRX (6.74) and PACAX (6.46) have marching annual gain over last year. PACAX return over 5 years is better than : 10.78 vs. JALRX (9.17).
| JALRX | PACAX | JALRX / PACAX | |
| Total Expense Ratio | 1.23 | 1.00 | 123% |
| Annual Report Gross Expense Ratio | 1.23 | 1.00 | 123% |
| Fund Existence | 20 years | 32 years | - |
| Gain YTD | 6.875 | 7.904 | 87% |
| Front Load | 5% | 6% | 78% |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | 1000 | N/A | - |
| Net Assets | 1.59B | 576M | 276% |
| Annual Yield % from dividends | 3.63 | 3.40 | 107% |
| Returns for 1 year | 6.74 | 6.46 | 104% |
| Returns for 3 years | 17.78 | 21.02 | 85% |
| Returns for 5 years | 9.17 | 10.78 | 85% |
| Returns for 10 years | 26.76 | 28.28 | 95% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement